Watt F E, James O F W, Jones D E J
Centre for Liver Research, University of Newcastle, Newcastle-upon-Tyne, UK.
QJM. 2004 Jul;97(7):397-406. doi: 10.1093/qjmed/hch078.
Primary biliary cirrhosis (PBC) is a chronic liver disease with autoimmune features but uncertain aetiology. Increased risk of PBC among relatives of patients may reflect common environmental factors, or inherited immunogenetic susceptibility. Associations between PBC and other autoimmune diseases have been reported, but their true extent and pattern is unknown.
To examine the prevalence and association patterns of autoimmune disease in a representative group of PBC patients.
Clinical cohort study.
We clinically assessed members of a geographically-based PBC patient cohort (n = 160) for the presence of additional autoimmune disease, using established specific diagnostic criteria.
Some 53% of patients had at least one additional autoimmune condition, and 63% had serum autoantibodies other than AMA or ANA. AMA+ patients had a significantly lower prevalence of additional autoimmunity than AMA- patients (49% vs. 79%; p < 0.01). The greatest relative increase in disease prevalence was for scleroderma (8% of patients). Autoimmune disease was present in 14% of first-degree relatives.
PBC patients and their families have a wide susceptibility to autoimmunity. This observation supports an autoimmune aetiology and suggests that the genetic basis of PBC is likely to be expressed, at least in part, through factors controlling immune tolerance in general.
原发性胆汁性肝硬化(PBC)是一种具有自身免疫特征但病因不明的慢性肝病。患者亲属中PBC风险增加可能反映了共同的环境因素或遗传免疫遗传易感性。已有报道称PBC与其他自身免疫性疾病之间存在关联,但其真实程度和模式尚不清楚。
研究一组具有代表性的PBC患者中自身免疫性疾病的患病率及关联模式。
临床队列研究。
我们使用既定的特定诊断标准,对一个基于地理位置的PBC患者队列(n = 160)的成员进行了额外自身免疫性疾病的临床评估。
约53%的患者至少有一种额外的自身免疫性疾病,63%的患者有除AMA或ANA之外的血清自身抗体。AMA阳性患者的额外自身免疫患病率显著低于AMA阴性患者(49%对79%;p < 0.01)。疾病患病率相对增加最多的是硬皮病(占患者的8%)。14%的一级亲属患有自身免疫性疾病。
PBC患者及其家族对自身免疫具有广泛的易感性。这一观察结果支持自身免疫病因学,并表明PBC的遗传基础可能至少部分通过一般控制免疫耐受的因素来表达。